HCV NS5B inhibitors

Details for Australian Patent Application No. 2007211988 (hide)

Owner Bristol-Myers Squibb Company

Inventors Bergstrom, Carl P.; Martin, Scott W.; Hudyma, Thomas W.

Agent A J Park

Pub. Number AU-B-2007211988

PCT Pub. Number WO2007/092888

Priority 60/771,391 08.02.06 US

Filing date 7 February 2007

Wipo publication date 16 August 2007

Acceptance publication date 2 February 2012

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

28 August 2008 PCT application entered the National Phase

  PCT publication WO2007/092888 Priority application(s): WO2007/092888

2 February 2012 Application Accepted

  Published as AU-B-2007211988

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007211996-An apparatus and method for fast access in a wireless communication system

2007211965-Alendronate for use in the treatment of osteoporosis